KR840006475A - 나프탈렌 유도체의 제조방법 - Google Patents

나프탈렌 유도체의 제조방법 Download PDF

Info

Publication number
KR840006475A
KR840006475A KR1019830005053A KR830005053A KR840006475A KR 840006475 A KR840006475 A KR 840006475A KR 1019830005053 A KR1019830005053 A KR 1019830005053A KR 830005053 A KR830005053 A KR 830005053A KR 840006475 A KR840006475 A KR 840006475A
Authority
KR
South Korea
Prior art keywords
optionally substituted
substituted phenyl
formula
compound
lower alkyl
Prior art date
Application number
KR1019830005053A
Other languages
English (en)
Other versions
KR880002309B1 (ko
Inventor
헨리존스(외 2) 고오든
Original Assignee
헤르비그 폰 모오즈
신텍스(유. 에스. 에이)인코퍼레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 헤르비그 폰 모오즈, 신텍스(유. 에스. 에이)인코퍼레이티드 filed Critical 헤르비그 폰 모오즈
Publication of KR840006475A publication Critical patent/KR840006475A/ko
Application granted granted Critical
Publication of KR880002309B1 publication Critical patent/KR880002309B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/12—Acetic acid esters
    • C07C69/16—Acetic acid esters of dihydroxylic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C07C205/46—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group the carbon skeleton containing carbon atoms of quinone rings
    • C07C205/47—Anthraquinones containing nitro groups
    • C07C205/48—Anthraquinones containing nitro groups the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00—Preparation of quinones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00—Preparation of quinones
    • C07C46/02—Preparation of quinones by oxidation giving rise to quinoid structures
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/24—Quinones containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
    • C07C50/32—Quinones containing groups having oxygen atoms singly bound to carbon atoms the quinoid structure being part of a condensed ring system having two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62—Halogen-containing esters
    • C07C69/63—Halogen-containing esters of saturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Steroid Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)

Abstract

내용 없음

Description

나프탈렌 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (9)

  1. 일반식(XI)의 화합물을 아실화함을 특징으로 하여 일반식(Ⅰ)의 화합물을 제조하는 방법.
    상기 일반식에서
    R1및 R2는 C4-C5저급알콕시 또는 C1-C6저급알킬티오이고 ;
    R3는 수소 C1-C6저급알킬, C1-C6저급알콕시, 임의 치환된 페닐, 임의 치환된 페닐 저급알킬, 임의 치환된 페닐저급알콕시 아미노, 저급알킬아미노, 저급디알킬아미노, 할로, 시아노
    또는 S(O)nR [여기서 R은 C1-C6저급알킬 ; 임의 치환된 페닐 ; 임의 치환된 페닐 저급알킬 ; 또는 질소, 산소 및 황으로부터 선택된 1개 또는 2개의 헤테로원자를 함유하는 3개 내지 9개의 환원자를 가진 헤테로사이클릭아릴(여기서 헤테로사이클릭아릴은 저급알킬, 저급알콕시, 할로 및 시아노로부터 선택된 1개 또는 그 이상의 치환제로 임의 치환될 수 있다)이고 n은 0, 1 또는 2이다], 및 이들의 약학적으로 허용된 산부가 염이며 ; W는 C1-C7알킬이고, 단 R1과 R2가 메톡시이고 W가 메틸인 경우, R3는 수소가 아니다.
  2. 제1항에 있어서 일반식(Ⅰ)' 의 화합물을 제조하는 방법.
    상기 일반식에서
    R1,R2,R3및 W는 제1항에서 정의한 바와 같다.
  3. 제2항에 있어서, R1과 R2가 C1-C6저급알콕시인 방법.
  4. 제3항에 있어서, R3가 플루오로, 클로로 및 브로모로부터 선택된 그룹인 방법.
  5. 제3항에 있어서, R3가 시아노인 방법.
  6. 제4항에 있어서, 6-클로로-2,3-디메톡시-1,4-아세틸옥시나프탈렌을 제조하는 방법.
  7. 제4항에 있어서, 6-클로로-2,3-디-m-부톡시-1,4-아세틸옥시나프탈렌을 제조하는 방법.
  8. 제2항에 있어서, R1과 R2가 C1-C6저급알킬티오인 방법.
  9. 제1항 내지 8항중의 어느 한 항에 있어서, 일반식(Ⅵ)의 화합물을 출발물질로 사용하는 방법.
    상기 일반식에서
    R1,R2및 R3는 제1항에서 정의된 바와 같다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019830005053A 1982-10-27 1983-10-26 나프탈렌 유도체의 제조방법 KR880002309B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/437,063 US4466981A (en) 1982-10-27 1982-10-27 Naphthalene anti-psoriatic agents
US437063 1982-10-27

Publications (2)

Publication Number Publication Date
KR840006475A true KR840006475A (ko) 1984-11-30
KR880002309B1 KR880002309B1 (ko) 1988-10-22

Family

ID=23734911

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830005053A KR880002309B1 (ko) 1982-10-27 1983-10-26 나프탈렌 유도체의 제조방법

Country Status (20)

Country Link
US (1) US4466981A (ko)
EP (1) EP0107512B1 (ko)
JP (1) JPS59104346A (ko)
KR (1) KR880002309B1 (ko)
AT (1) ATE18196T1 (ko)
AU (1) AU577772B2 (ko)
CA (1) CA1285575C (ko)
DE (1) DE3362342D1 (ko)
DK (1) DK164105C (ko)
ES (1) ES8504098A1 (ko)
FI (1) FI78901C (ko)
HK (1) HK3588A (ko)
HU (1) HU195470B (ko)
IE (1) IE56603B1 (ko)
MX (1) MX9203164A (ko)
MY (1) MY8700831A (ko)
NO (1) NO158216C (ko)
NZ (1) NZ206071A (ko)
SG (1) SG94687G (ko)
ZA (1) ZA837983B (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4593120A (en) * 1982-10-27 1986-06-03 Syntex (U.S.A.) Inc. Naphthalene anti-psoriatic agents
DK35885A (da) * 1984-01-27 1985-07-28 Syntex Inc Naphthalenderivater
US4833164A (en) * 1985-05-08 1989-05-23 E. I. Du Pont De Nemours And Company 2-substituted-1-naphthols, pharmaceutical compositions of, and their use as 5-lipoxygenase inhibitors
US4792556A (en) * 1985-09-09 1988-12-20 Syntex (U.S.A.) Inc. Naphthalene anti-psoriatic agents
JPS6284046A (ja) * 1985-09-09 1987-04-17 シンテツクス（ユ−・エス・エイ）インコ−ポレイテツド ナフタレン系抗乾癬剤
US4933489A (en) * 1985-10-24 1990-06-12 Warner-Lambert Company Process for the manufacture of 6-chloro-1,4-diacetoxy-2,3-dimethoxynaphthalene
DE3623360A1 (de) * 1986-07-11 1988-01-14 Cameron Iron Works Gmbh Einrichtung mit einander benachbarten oberflaechen, zwischen denen hohe druecke und/oder hohe reibungsbeanspruchungen auftreten
US5134161A (en) * 1987-03-09 1992-07-28 Syntex (U.S.A.) Inc. Method for treating disease states in mammals with naphthalene lipoxygenase-inhibiting agents
US4758587A (en) * 1987-03-09 1988-07-19 Syntex (U.S.A.) Inc. Naphthalene anti-psoriatic agents
US4786652A (en) * 1987-03-09 1988-11-22 Syntex (U.S.A.) Inc. Naphthalene anti-psoriatic agents
US5155132A (en) * 1987-03-09 1992-10-13 Syntex (U.S.A.) Inc. Naphthalene lipoxygenase-inhibiting agents
FI881065A (fi) * 1987-03-09 1988-09-10 Syntex Inc Foerfarande foer framstaellning av naftalenfoereningar anvaendbara vid behandling av psoriasis.
US5089657A (en) * 1987-03-11 1992-02-18 Syntex (U.S.A.) Inc. Naphthalene anti-psoriatic agents
US4925831A (en) * 1987-06-11 1990-05-15 Merck & Co., Inc. Aminoalkyl naphthalenediols as host resistance enhancers against viral infection
US4840965A (en) * 1987-07-07 1989-06-20 Syntex (U.S.A.) Inc. Naphthalene anti-psoriatic agents
US5242946A (en) * 1988-10-27 1993-09-07 Bio-Mega, Inc. Treating herpes Viral infections

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3714206A (en) * 1968-12-02 1973-01-30 Gruenenthal Chemie Benzo-2,3,1-diazaborines
CH575904A5 (ko) * 1972-02-16 1976-05-31 Eisai Co Ltd
US4115060A (en) * 1977-10-03 1978-09-19 Fmc Corporation N-sulfonylimidazoles as peroxygen activators
US4255408A (en) * 1977-11-11 1981-03-10 Thermo-Mist Company Process for removing sulfur and sulfur compounds from the effluent of industrial processes
US4181741A (en) * 1977-11-18 1980-01-01 E. I. Du Pont De Nemours And Company Naphthalene miticides
US4321373A (en) * 1978-03-18 1982-03-23 Hoechst Aktiengesellschaft 2-Hydroxy-3-naphthoic acid amides
US4229478A (en) * 1978-06-05 1980-10-21 Syntex (U.S.A.) Inc. Naphthaquinone anti-psoriatic agents
US4255405A (en) * 1978-06-05 1981-03-10 Syntex (U.S.A.) Inc. Naphthoquinone anti-psoriatic agents
US4374855A (en) * 1981-04-03 1983-02-22 Gaf Corporation Fungicidal naphthylene diesters and mixtures thereof
US4593120A (en) * 1982-10-27 1986-06-03 Syntex (U.S.A.) Inc. Naphthalene anti-psoriatic agents

Also Published As

Publication number Publication date
IE832503L (en) 1984-04-27
IE56603B1 (en) 1991-10-09
ES526785A0 (es) 1985-04-16
HK3588A (en) 1988-01-22
EP0107512A1 (en) 1984-05-02
FI78901B (fi) 1989-06-30
MX9203164A (es) 1992-07-01
HUT35238A (en) 1985-06-28
FI833907A0 (fi) 1983-10-26
DK164105B (da) 1992-05-11
AU577772B2 (en) 1988-10-06
AU2058083A (en) 1984-05-03
ES8504098A1 (es) 1985-04-16
NO158216C (no) 1988-08-03
ZA837983B (en) 1985-06-26
DE3362342D1 (en) 1986-04-03
ATE18196T1 (de) 1986-03-15
CA1285575C (en) 1991-07-02
NZ206071A (en) 1986-09-10
MY8700831A (en) 1987-12-31
US4466981A (en) 1984-08-21
NO158216B (no) 1988-04-25
KR880002309B1 (ko) 1988-10-22
DK492283A (da) 1984-04-28
HU195470B (en) 1988-05-30
FI833907A (fi) 1984-04-28
DK492283D0 (da) 1983-10-26
FI78901C (fi) 1989-10-10
JPS59104346A (ja) 1984-06-16
NO833900L (no) 1984-04-30
EP0107512B1 (en) 1986-02-26
JPH0520420B2 (ko) 1993-03-19
SG94687G (en) 1988-05-06
DK164105C (da) 1992-10-05

Similar Documents

Publication Publication Date Title
KR850003890A (ko) 1H-이미다조[4,5c]-퀴놀린-4-아민의 제조방법
KR840006475A (ko) 나프탈렌 유도체의 제조방법
KR880013888A (ko) 신규 디티오아세탈 화합물, 그의 제조방법 및 이 화합물로 되는 제약 조성물
KR870004030A (ko) 축합 이미다조 피리딘 유도체
KR870002125A (ko) 피리딘 유도체의 제조방법
KR850003402A (ko) 2-아미노-5-하이드록시-4-메틸 피리미딘 유도체의 제조방법
KR920021547A (ko) 아졸 유도체
KR880000413A (ko) 항알레르기 및 소염 제제와 그의 제조방법
KR840004345A (ko) 피라졸 유도체 및 그것의 제조방법과 유효성분으로서 그것을 함유하는 선택적인 제초조성물, 그리고 그것을 사용하여 잡초를 제거하고 억제하는 방법.
KR850004585A (ko) 신규 아미노과니딘 유도체의 제조방법
KR850004574A (ko) 나프탈렌 유도체의 제조방법
KR840006482A (ko) 디히드로피라졸로 [3,4-b]피리딘 유도체의 제조방법
KR830005110A (ko) 플루오렌 유도체의 제조방법
KR840006207A (ko) 6-치환된-퀴놀린-5,6-퀴논의 제조방법
KR860003240A (ko) 1,2,4- 트리아졸로- 카바메이트의 제조방법
KR860001808A (ko) 이미다조〔1,5-a〕피리미딘 유도체의 제조방법
KR840005717A (ko) 벤즈아미드 유도체의 제조방법
KR850001200A (ko) 아졸계 디옥솔란 유도체의 제조방법
KR830004210A (ko) 2-아미노-3-벤조일-페닐아세트아미드 및 환상 동족체
KR850005397A (ko) 나프탈렌 유도체의 제조방법
KR860006453A (ko) 트리아지닐을 함유하는 스틸벤 유도체의 제조방법
DK240283A (da) Beta-carbolin-3-carboxylsyrederivater og fremgangsmaade til fremstilling af samme
KR870004038A (ko) 제초제 화합물의 제조방법
KR860002474A (ko) 치환된 페닐술포닐아졸의 제조방법
KR890008151A (ko) 키놀린 카르복산의 유도체

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19920731

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee